Terpos, E., Gavriatopoulou, M., Ntanasis-Stathopoulos, I., Kanellias, N., Solia, E., Malandrakis, P., Spiliopoulou, V., Theodorakakou, F., Migkou, M., Papaiakovou, E. E., Fotiou, D., Gkolfinopoulos, S., Kastritis, E., Dimopoulos, M. A. (2025). Belantamab mafodotin plus lenalidomide/dexamethasone in newly diagnosed intermediate-fit & frail multiple myeloma patients: Long-term efficacy and safety from the phase 1/2 BELARD clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7512